Absorption of iron from grape-molasses and ferrous sulfate: a comparative study in normal subjects and subjects with iron deficiency anemia
- PMID: 9433148
Absorption of iron from grape-molasses and ferrous sulfate: a comparative study in normal subjects and subjects with iron deficiency anemia
Abstract
We compared the absorption of iron from grape molasses (GM) and ferrous sulfate (FS) using the post-absorptive serum iron increase method (non-radioactive). The study involved 56 subjects, aged 6-36 months. Group I consisted of 30 subjects with iron deficiency anemia (IDA) and group II, 26 non-anemic subjects. Each group was subdivided randomly into two equal subgroups to be given either GM or FS. The absorption of the iron from GM was monitored in 15 infants with IDA and in 13 non-anemic infants, and the absorption of iron from FS was tested in the rest of the subjects in each group. In those infants in each group given GM or FS, there was no significant difference in before-test values for serum iron (SI) and total iron binding capacity (TIBC) (p > 0.05). In the group with IDA, the mean after-test SI value in FS-given infants was higher and the mean TIBC value lower than those of GM-given infants (p < 0.05). However, in the non-anemic group, there was no significant difference in the mean after-test SI and TIBC values in either GM- or FS-given infants (p > 0.05). The mean increase of serum iron in GM-given infants with IDA was 27.0 +/- 13.4 micrograms/ dl and in FS-given infants, 60.6 +/- 17.0 micrograms/dl (p < 0.05). In the non-anemic group, the mean increase of serum iron of GM-given infants was 23.0 +/- 4.3 micrograms/dl, and that of FS-given infants, 23.8 +/- 10.0 micrograms/dl (p > 0.05). We determined that in non-anemic subjects, the absorption of iron from GM was comparable to that from FS. Furthermore, we believe that grape molasses is an effective iron source in preventing iron deficiency anemia in infancy.
Similar articles
-
A comparative study of iron bioavailability from cocoa supplemented with ferric pyrophosphate or ferrous fumarate in rats.Ann Nutr Metab. 2007;51(3):204-7. doi: 10.1159/000104138. Epub 2007 Jun 18. Ann Nutr Metab. 2007. PMID: 17587790
-
Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.Indian Pediatr. 2009 Oct;46(10):883-5. Epub 2009 Apr 1. Indian Pediatr. 2009. PMID: 19430060 Clinical Trial.
-
Milk versus medicine for the treatment of iron deficiency anaemia in hospitalised infants.Arch Dis Child. 2005 Oct;90(10):1033-8. doi: 10.1136/adc.2004.067876. Epub 2005 Jun 14. Arch Dis Child. 2005. PMID: 15956047 Free PMC article. Clinical Trial.
-
Prevention of iron deficiency in infants and toddlers.Am Fam Physician. 2002 Oct 1;66(7):1217-24. Am Fam Physician. 2002. PMID: 12387433 Review.
-
Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis.Arzneimittelforschung. 2007;57(6A):431-8. doi: 10.1055/s-0031-1296692. Arzneimittelforschung. 2007. PMID: 17691593 Review.
Cited by
-
Evaluating the effect of grape syrup on iron deficiency anemia in women: A randomized clinical trial.Food Sci Nutr. 2024 May 6;12(8):5473-5479. doi: 10.1002/fsn3.4185. eCollection 2024 Aug. Food Sci Nutr. 2024. PMID: 39139942 Free PMC article.
-
The effect of reticulocyte hemoglobin content on the diagnosis of iron deficiency anemia: A meta-analysis study.J Med Biochem. 2022 Feb 2;41(1):1-13. doi: 10.5937/jomb0-31435. J Med Biochem. 2022. PMID: 35291499 Free PMC article.